• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Everolimus (1)

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
 
Labeling Sections with
Pharmacogenomic
Information
EverolimusOncologyERBB2HER2 protein
overexpression negative
Indications and Usage
Boxed Warning
Adverse Reactions
Use in Specific Populations
Clinical Pharmacology
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling